OverviewSuggest Edit

Eli Lilly and Company is a company that discovers, develops, manufactures, and markets pharmaceutical products. The company offers diabetes and endocrinology, immunology, neuroscience, oncology, and other products. Its products are distributed through wholesalers that serve pharmacies, physicians and other health care professionals, and hospitals.

TypePublic
Founded1876
HQIndianapolis, IN, US
Websitelilly.com
Employee Ratings4.1
Overall CultureA-

Latest Updates

Employees (est.) (Dec 2019)33,625(-13%)
Job Openings705
Revenue (FY, 2020)$24.5 B(+10%)
Share Price (Jun 2021)$224.1(-4%)
Cybersecurity ratingCMore

Key People/Management at Eli Lilly

David A. Ricks

David A. Ricks

Chairman and Chief Executive Officer
Melissa Stapleton Barnes

Melissa Stapleton Barnes

Senior Vice President, Enterprise Risk Management, and Chief Ethics and Compliance Officer
Stephen F. Fry

Stephen F. Fry

Senior Vice President, Human Resources and Diversity
Johna L. Norton

Johna L. Norton

Senior Vice President, Global Quality
Myles O'Neill

Myles O'Neill

Senior Vice President and President, Manufacturing Operations
Leigh Ann Pusey

Leigh Ann Pusey

Senior Vice President, Corporate Affairs and Communications
Show more

Eli Lilly Office Locations

Eli Lilly has offices in Indianapolis, Branchburg, Cambridge, New York and in 36 other locations
Indianapolis, IN, US (HQ)
893 Delaware St
Branchburg, NJ, US
33 Imclone Dr
Cambridge, MA, US
450 Kendall St
Indianapolis, IN, US
1223 W Morris St
Indianapolis, IN, US
1500 S Harding St
New York, NY, US
450 E 29th St 12th floor
Show all (42)

Eli Lilly Financials and Metrics

Eli Lilly Revenue

Embed Graph
View revenue for all periods
Eli Lilly's revenue was reported to be $24.54 b in FY, 2020
USD

Revenue (Q1, 2021)

6.8b

Gross profit (Q1, 2021)

4.9b

Gross profit margin (Q1, 2021), %

72.4%

Net income (Q1, 2021)

1.4b

Market capitalization (11-Jun-2021)

215.0b

Closing stock price (11-Jun-2021)

224.1

Cash (31-Mar-2021)

3.0b

EV

228.2b
Eli Lilly's current market capitalization is $215 b.
Annual
USDFY, 2017FY, 2018FY, 2019FY, 2020

Revenue

22.9b24.6b22.3b24.5b

Revenue growth, %

7%(9%)

Cost of goods sold

6.1b6.4b4.7b5.5b

Gross profit

16.8b18.1b17.6b19.1b
Quarterly
USDQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Revenue

5.7b6.4b6.1b5.1b5.6b5.5b5.9b5.5b5.7b6.8b

Cost of goods sold

1.6b1.7b1.6b1.1b1.1b1.2b1.2b1.2b1.3b1.9b

Gross profit

4.1b4.7b4.5b4.0b4.5b4.3b4.6b4.3b4.4b4.9b

Gross profit Margin, %

72%73%74%78%80%79%79%78%77%72%
Annual
USDFY, 2017FY, 2018FY, 2019FY, 2020

Cash

6.5b8.0b2.3b3.7b

Accounts Receivable

4.5b5.2b4.5b5.9b

Prepaid Expenses

1.4b2.1b2.5b2.9b

Inventories

4.5b4.1b3.2b4.0b
Quarterly
USDQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Cash

3.1b6.8b9.0b2.0b2.3b1.6b1.7b2.4b3.6b3.0b

Accounts Receivable

4.5b4.8b4.9b4.2b4.6b4.4b5.1b4.8b4.9b5.6b

Prepaid Expenses

1.6b1.7b1.9b2.2b2.3b2.4b2.8b3.1b3.2b3.2b

Inventories

4.6b4.2b4.1b3.1b3.2b3.1b3.1b3.3b3.6b3.7b
Annual
USDFY, 2017FY, 2018FY, 2019FY, 2020

Net Income

(204.1m)3.2b8.3b6.2b

Depreciation and Amortization

1.6b1.6b1.2b1.3b

Inventories

(253.9m)7.8m(258.7m)(533.4m)

Accounts Payable

916.3m(284.5m)(477.7m)1.3b
Quarterly
USDQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Net Income

1.2b957.5m2.1b4.2b5.6b6.8b1.5b2.9b4.1b1.4b

Depreciation and Amortization

422.8m848.0m1.3b356.5m603.9m891.9m273.6m598.0m956.4m350.3m

Cash From Operating Activities

436.5m2.0b4.1b311.3m1.4b2.9b382.4m2.9b4.7b1.7b

Purchases of PP&E

(236.5m)(546.5m)(816.3m)(203.7m)(444.0m)(707.4m)(258.3m)(540.1m)(933.2m)(300.3m)
USDFY, 2017

Revenue/Employee

562.6k

Debt/Equity

1.2 x

Debt/Assets

0.3 x

Financial Leverage

3.9 x
Show all financial metrics

Eli Lilly Operating Metrics

FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Countries

125125125125120

Phase III Trials Products

87171971915

Projects in R&D Pipeline

57576566

Phase I Trials Products

212227
Show all operating metrics

Eli Lilly Acquisitions / Subsidiaries

Company NameDateDeal Size
Disarm TherapeuticsOctober 15, 2020$135 m
DermiraJanuary 10, 2020$1.1 b
Loxo OncologyJanuary 07, 2019$6.92 b
AurKa PharmaMay 15, 2018$575 m
ARMO BioSciences IncMay 11, 2018$1.6 b
CoLucid PharmaceuticalsJanuary 18, 2017$960 m
Novartis Animal HealthApril 22, 2014$5.4 b
Lohmann Animal HealthFebruary 24, 2014
ChemGenJanuary 24, 2012
Avid RadiopharmaceuticalsNovember 08, 2010$800 m
Show more

Eli Lilly Revenue Breakdown

Embed Graph

Eli Lilly revenue breakdown by geographic segment: 11.4% from Japan, 16.9% from Europe, 57.0% from United States and 14.7% from Other foreign countries

Human Capital Metrics

Embed Graph
Show all human capital metrics

Eli Lilly Cybersecurity Score

Cybersecurity ratingPremium dataset

C

73/100

SecurityScorecard logo

Eli Lilly Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

50-59

out of 100

CSRHub logo

Eli Lilly Online and Social Media Presence

Embed Graph

Eli Lilly Company Culture

  • Overall Culture

    A-

    73/100

  • CEO Rating

    A-

    74/100

  • Compensation

    A

    79/100

  • Diversity

    C+

    67/100

Learn more on Comparably

Eli Lilly News and Updates

Thinking about trading options or stock in Eli Lilly, Pfizer, GameStop, Cleveland-Cliffs, or FuelCell Energy?

NEW YORK, June 10, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for LLY, PFE, GME, CLF, and FCEL. Click a link below then choose between in-depth options trade idea report or a stock score report. Options Report – Ideal trade ideas on up to seven different...

Can The Rally Continue For Eli Lilly Stock After A 10% Rise On Increased Hopes For Its Alzheimer’s Drug

The stock price of Eli Lilly & Company (NYSE: LLY) has seen a large 10% rise in a single trading session yesterday. This move came after Biogen’s Aduhelm was approved by the U.S. FDA for the treatment of Alzheimer’s disease...

Stocks making the biggest moves midday: Biogen, Eli Lilly and AMC

These are the stocks posting the largest moves in midday trading.

Eli Lilly India gets nod for emergency use of antibody drugs combination for COVID-19

The company has received permission for restricted emergency use of its monoclonal antibody drugs, Bamlanivimab 700 mg and Etesevimab 1400 mg, used together for the treatment of patients with mild to moderate COVID-19, Eli Lilly said in a statement.

Global Animal Health Market (2021 to 2025) - Featuring Bayer, Eli Lilly and Zoetis Among Others

Dublin, May 25, 2021 (GLOBE NEWSWIRE) -- The "Global Animal Health Market (Feed Additives, Pharmaceuticals & Vaccines): Insights & Forecast with Potential Impact of COVID-19 (2021-2025)" report has been added to ResearchAndMarkets.com's offering.

Global Insulin Pens, Syringes, Pumps and Injectors Market 2021-2030 with Novo Nordisk A/S, Eli Lilly and Co, Medtronic, Abbott, and Insulet Dominating

Dublin, May 24, 2021 (GLOBE NEWSWIRE) -- The "Insulin Pens, Syringes, Pumps and Injectors Global Market Report 2021: COVID-19 Implications and Growth to 2030" report has been added to ResearchAndMarkets.com's offering. Major players in the insulin pens, syringes, pumps and injectors market are Nov…
Show more

Eli Lilly Frequently Asked Questions

  • When was Eli Lilly founded?

    Eli Lilly was founded in 1876.

  • Who are Eli Lilly key executives?

    Eli Lilly's key executives are David A. Ricks, Melissa Stapleton Barnes and Stephen F. Fry.

  • How many employees does Eli Lilly have?

    Eli Lilly has 33,625 employees.

  • What is Eli Lilly revenue?

    Latest Eli Lilly annual revenue is $24.5 b.

  • What is Eli Lilly revenue per employee?

    Latest Eli Lilly revenue per employee is $729.8 k.

  • Who are Eli Lilly competitors?

    Competitors of Eli Lilly include Boehringer Ingelheim, Sanofi and Becton Dickinson.

  • Where is Eli Lilly headquarters?

    Eli Lilly headquarters is located at 893 Delaware St, Indianapolis.

  • Where are Eli Lilly offices?

    Eli Lilly has offices in Indianapolis, Branchburg, Cambridge, New York and in 36 other locations.

  • How many offices does Eli Lilly have?

    Eli Lilly has 42 offices.